BioCentury
ARTICLE | Clinical News

Xtandi enzalutamide regulatory update

August 19, 2013 7:00 AM UTC

Medivation disclosed in its 2Q13 earnings that it submitted regulatory applications in Argentina, Australia, Brazil, South Africa and Switzerland for Xtandi enzalutamide to treat metastatic castration...